Genetic Diagnosis of Dysplasminogenemia: Detection of an Ala601 -Thr Mutation in 118 out of 125 Families and Identification of a New Asp676-Asn Mutation

Summary

Dysplasminogenemia (plasminogen abnormality) is frequently found in association with thrombosis. Two types of mutation, Ala601-Thr and Val355-Phe, have already been identified; the precise genetic defects of most of these patients, however, remain unknown. In this study, we examined the genetic DNAs of two unrelated cases by single-strand conformational polymorphism and nucleotide sequencing analysis. A new mutation, designated as Asp676-Asn, has been identified in these cases. This mutation leads to the loss of a negatively-charged residue and the creation of a potential carbohydrate attachment site, which may impair the enzymatic properties of plasminogen. As many as 158 individuals with dysplasminogenemia were analyzed by a combination of in vitro amplification and restriction digestion. Among 125 unrelated families, the Ala601-Thr mutation accounted for about 94% of cases. The Val355-Phe mutation was found in four unrelated families, indicating that it is a recurring mutation and is not very rare.

• References

• 1 Robbins KC. Dysplasminogenemia. Prog Cardiovasc Dis 1992; 34: 295-308
• 2 Aoki N, Moroi M, Sakata Y, Yoshida N, Matsuda M. Abnormal plasminogen. J Clin Invest 1978; 61: 1186-1195
• 3 Nishimukai H, Kera Y, Sakata K, Yamasawa K. Genetic polymorphism of plasminogen: A new basic variant (PLG B) and population study in Japanese. Vox Sang 1981; 40: 422-425
• 4 Aoki N, Tateno K, Sakata Y. Differences of frequency distributions of plasminogen phenotypes between Japanese and American populations: New methods for the detection of plasminogen variants. Biochem Genet 1984; 22: 871-881
• 5 Yamaguchi M, Doi S, Yoshimura M. Plasminogen phenotypes in a Japanese population. Hum Hered 1989; 39: 356-360
• 6 Skoda U, Klein A, Lubcke I, Mauff G, Pulverer G. Application of plasminogen polymorphism to forensic hemogenetics. Electrophoresis 1988; 9: 422-426
• 7 Ichinose A, Espling ES, Takamatsu J, Saito H, Shinmyozu K, Maruyama I, Petersen TE, Davie EW. Two types of abnormal genes for plasminogen in families with a predisposition for thrombosis. Proc Natl Acad Sci USA 1991; 88: 115-119
• 8 Azuma H, Uno Y, Shigekiyo T, Saito S. Congenital plasminogen deficiency caused by a Ser572 to Pro mutation. Blood 1993; 82: 475-480
• 9 Saiki RK, Gelfand DH, Stoffel S, Schaf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-491
• 10 Petersen TE, Martzen MR, Ichinose A, Davie EW. Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system. J Biol Chem 1990; 265: 6104-6111
• 11 Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reactions. Genomics 1989; 5: 874-879
• 12 Hongyo T, Buzard GS, Calvert RJ, Weghorst CM. ‘Cold SSCP’: a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucleic Acids Res 1993; 21: 3637-3642
• 13 Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5468
• 14 Li L, Kikuchi S, Arinami T, Hamaguchi H. Plasminogen with type-I mutation in the Chinese Han population. Clin Genet 1994; 45: 285-287
• 15 Liu Y, Lyons RM, McDonagh J. Plasminogen San Antonio: An abnormal plasminogen with a more cathodic migration, decreased activation and associated thrombosis. Thromb Haemost 1988; 59: 49-53
• 16 Girolami A, Sartori MT, Saggiorato G, Sgarabotto D, Patrassi GM. Symptomatic versus asymptomatic patients in congenital hypoplasminogenemia: a statistical analysis. Haematol 1994; 26: 59-65
• 17 Ploplis VA, Carmeliet P, Vazirzadeh S, Vlaenderen IV, Moons L, Plow EF, Collen D. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation 1995; 92: 2585-2593